Colin McLean, managing director of SVM Asset Management, explains why Croda remains an undervalued stock despite its strong rise this year.
Croda Despite a gain of 80% this year, Croda's share price still undervalues its business. The market seems to be underestimating the radical overhaul this company has had, and the potential for further profits progress. Since 2007, Croda has been transformed by shrinking its balance sheet, and moving capital towards higher margin businesses. An added attraction is the potential for a bid for this trophy asset. Capitalised at £2bn, Croda is a world leader in the production of natural-based speciality chemicals. The group operates two key divisions which contribute approxima...
To continue reading this article...
Join Investment Week for free
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes